Article
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
BMC cancer - 19 Aug 2015
Harmsen Marline G, Arts-de Jong Marieke, Hoogerbrugge Nicoline, Maas Angela H E M, Prins Judith B, Bulten Johan, Teerenstra Steven, Adang Eddy M M, Piek Jurgen M J, van Doorn Helena C, van Beurden Marc, Mourits Marian J E, Zweemer Ronald P, Gaarenstroom Katja N, Slangen Brigitte F M, Vos M Caroline, van Lonkhuijzen Luc R C W, Massuger Leon F A G, Hermens Rosella P M G, de Hullu Joanne A
Abstract excerpt
BACKGROUND: Risk-reducing salpingo-oophorectomy (RRSO) around the age of 40 is currently recommended to BRCA1/2 mutation carriers. This procedure decreases the elevated ovarian cancer risk by 80-96% but it initiates premature menopause as well. The latter is associated with short-term and long-term morbidity, potentially affecting quality of life (QoL). Based on recent insights into the Fallopian tube as possible...
Topics
- Adult
- BRCA1 Protein
- BRCA2 Protein
- Cystadenocarcinoma, Serous
- Female
- Genetic Predisposition to Disease
- Humans
- Incidence
